Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-219,485
Closed -$7.7M 80
2020
Q1
$7.7M Buy
219,485
+6,585
+3% +$314K 0.72% 53
2019
Q4
$11.1M Sell
212,900
-177
-0.1% -$8.81K 0.88% 46
2019
Q3
$10.8M Buy
213,077
+1,832
+0.9% +$90.1K 0.97% 43
2019
Q2
$10.1M Sell
211,245
-815
-0.4% -$37.7K 0.93% 46
2019
Q1
$10.3M Sell
212,060
-277
-0.1% -$12.5K 0.95% 46
2018
Q4
$8.73M Buy
212,337
+27,218
+15% +$1.12M 0.93% 44
2018
Q3
$7.59M Sell
185,119
-195
-0.1% -$7.88K 0.72% 57
2018
Q2
$7.37M Buy
185,314
+2,320
+1% +$89.2K 0.76% 57
2018
Q1
$6.84M Buy
+182,994
New +$7.39M 0.73% 57

Other funds holding HOLX

NS Partners's HOLX Position: Q2 2020 in Review

NS Partners sold out of Hologic (HOLX) in Q2 2020, closing a stake of 219,485 shares — an estimated $7.7M sold.

NS Partners first reported a position in HOLX in Q1 2018 and held it in 9 quarters. The position peaked at $11.1M in Q4 2019. 522 funds tracked by Wall St. Rank hold HOLX as of Q2 2020.

  • NS Partners reported no remaining Hologic position as of Q2 2020 after selling out during the quarter.
  • NS Partners sold 219,485 Hologic shares in Q2 2020, an estimated $7.7M.
  • NS Partners first reported a position in Hologic in Q1 2018 and held it in 9 quarters.
  • NS Partners's Hologic position peaked at $11.1M in Q4 2019.
  • 522 funds tracked by Wall St. Rank held Hologic as of Q2 2020.

Based on NS Partners's 13F filing for Q2 2020, filed 13 Aug 2020.